What does 2023 hold for oral solid dosage forms?
Recipharm’s Uwe Hanenberg, Head of Product Development, Oral Solid Dose, and Maria Lundin-Johnson, Head of Formulation Development, explore the latest trends shaping the oral solid dosage (OSD) form market and the high-level dilemmas they pose for the industry. They will discuss how new excipients can help pharmaceutical companies to keep up with these new developments